Evidence map›Paper›PMID 40269768›Full record

ArticleBMC infectious diseases2025

Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV- 2 infection in Ontario, Canada.

Savana Bosco, Amy Peng, Ashleigh R Tuite, Alison Simmons, David N Fisman

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Savana BoscoDalla Lana School of Public Health, University of Toronto, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada.
Amy PengDalla Lana School of Public Health, University of Toronto, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada.
Ashleigh R TuiteDalla Lana School of Public Health, University of Toronto, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada.
Alison SimmonsDalla Lana School of Public Health, University of Toronto, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada.
David N FismanDalla Lana School of Public Health, University of Toronto, Room 686, 155 College Street, ON, M5 T 3M7, Toronto, Canada. david.fisman@utoronto.ca.

Funding

CIHR OV4-170360
6 · The paper itself

Abstract

Communicable disease surveillance typically relies on case counts for estimates of risk, and counts can be strongly influenced by testing rates. In the Canadian province of Ontario, testing rates varied markedly by age, sex, geography and time over the course of the SARS-CoV-2 pandemic. We applied a standardization-based approach to test-adjustment to better understand pandemic dynamics from 2020 to 2022, and to better understand when test-adjustment is necessary for accurate estimation of risk. Case counts were adjusted for under-testing using a previously published standardization-based approach that estimates case numbers that would have been expected if the entire population was tested at the same rate as most-tested age and sex groups. After adjustment for under-testing, estimated case counts increased threefold and test-adjusted cases correlated better with SARS-CoV-2-attributed death than crude reported cases. Test-adjusted epidemic curves suggested, in contrast to reported case counts, that the first two pandemic waves were equivalent in size, and identified three distinct pandemic waves in 2022, due to the emergence of Omicron variants. Under-reporting was greatest in younger individuals, with variation explained partly by testing rates and prevalence of multigenerational households; test-adjustment resulted in little change in the epidemic curve during time periods when per capita testing rates exceeded 5.5%. We conclude that standardization-based adjustment for differential testing by age and sex results in a different understanding of the epidemiology of SARS-CoV-2 in Ontario. This methodology may offer a means of deriving adjusted estimates of infection incidence from surveillance data, accounting for fluctuations due to changing test practices.

Indexed as

COVID-19COVID-19 TestingSARS-CoV-2AdolescentAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedEpidemiologyPandemicsSARS-CoV-2Statistical methodsTestingValidation

Identifiers

PMID40269768
PMCPMC12020243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.